ImaBiotech Introduces Novel Panel to Its Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development
ImaBiotech unveils today its "Immune Signature Panel" as part of its Imaging Mass Cytometry Services. The new panel will be presented in exclusivity at the #AACR22 meeting in New Orleans where ImaBiotech is holding the booth #825 in the exhibit hall.ImaBiotech pioneered Imaging Mass Cytometry (IMC) applications for Biopharma launching its service in 2020. As a leading-edge technology, IMC enables highly multiplexed immunohistochemistry (mIHC) with simultaneous detection of up to 40 protein markers in the same tissue section with subcellular, single cell resolution.
Immune protection by cancer cells is mediated by the action of multiple immune-regulatory cell types, and the IMC technology allows to identify the key informative spatial information to more accurately profile those cells and understand their behavior. Combined with mass spectrometry imaging (MSI) developed by ImaBiotech, these molecular techniques are becoming game changer in the pharmaceutical industry by providing deeper information on drug localization and its efficacy. These innovative capabilities are also combined with powerful proprietary image analysis to help our clients evaluate targeted biomarkers for preclinical and clinical samples and classify patients based on tissue biomarkers.
"We are really pleased to pursue cutting-edge technology that can positively affect patient lives and our Imaging Mass Cytometry capability is a reflection of our dedication to service excellence", said Jonathan Stauber, CEO and Founder of ImaBiotech. "ImaBiotech unique experience and outstanding capabilities help ensure the successful execution of clinical patient sample analysis", he added.
152 Rue du Dr Yersin
Loos, 59360
France
Contact ImaBiotech:
Corinne Ramos - Innovation and Marketing Director
Tel. +33 (0) 374 095 546
Email ramos.corinne@imabiotech.com
ImaBiotech is a unique innovative bioanalytical service company to support new drug development programs. ImaBiotech combines standards bioanalytical methods with advanced mass spectrometry imaging and spatial biology (histology, multi-omics, spatialomics) techniques in order to decipher the complexity of drug activities. The combination of unique capabilities with advanced digital pathology tools makes possible the measurement of drug activity and drug response, simultaneously, at the single cell level. This performance enables comprehensive drug efficacy evaluation from preclinical to clinical stages. Founded in 2010, based in Lille, France, with a subsidiary in the US, ImaBiotech has received an award for the most innovative start-up company in France with 47 patents applied worldwide by Forbes and Patent-angels.com.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ImaBiotech Introduces Novel Panel to Its Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development here
News-ID: 2594278 • Views: …
More Releases from ImaBiotech
Black Pepper Processing Plant Setup Cost, Report 2024, Business Plan, Cost and R …
IMARC Group's report, titled "Black Pepper Processing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a complete roadmap for setting up a black pepper processing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more.
In addition…
Mass Spectrometry Imaging (MSI) Award 2016
The award ceremony was held at the Imaging MS: Present and Future of Multimodal Studies workshop at the ASMS Congress on Wednesday, June 8 in San Antonio, Texas in the presence of Vilmos Kertesz, (Oak Ridge National Laboratory, a Department of Energy facility) and Raf Van de Plas (Delft, University of Technology), coordinators of the Imaging MS Interest Group.
The panel of judges was chaired by ImaBiotech’s CEO, Jonathan Stauber,…
ImaBiotech signs license agreement with Lawrence Berkeley National Laboratory
Lille, France and Berkeley, California, USA – 15th April, 2016 – ImaBiotech, a CRO company developing and offering mass spectrometry imaging (MSI) services, applications, and software, announces today a license agreement with Lawrence Berkeley National Laboratory (Berkeley Lab) to “OpenMSI” intellectual property to support ImaBiotech Multimaging™ technology.
ImaBiotech’s Multimaging™ technology accelerates drug pharmacokinetic, pharmacology, toxicology, and formulation evaluation. Multimaging™ allows for the combination and overlay of different image files acquired…
ImaBiotech’s first worldwide patent has been granted for its quantification in …
Lille, France – 29th March, 2016 – First worldwide patent has been granted covering ImaBiotech’s research and services platform in the field of Mass spectrometry Imaging (MSI).
ImaBiotech, a CRO company developing and offering new imaging technologies, applications, and software, announces today that the company has been granted a patent in USA, France, Australia and China for its lead innovation on quantitative MS Imaging (QMSI) and the development of the associated…
More Releases for Imaging
Mobile Gamma Cameras Market 2018 -- 2028 | By Indication Type (Cardiac Imaging, …
Mobile gamma camera is a portable version of the stationary gamma or angler camera used for nuclear imaging. Nuclear imaging involves injecting a radio nucleotide in the body or organ under study and record the resulting redioactivity by scanning with a gamma camera. Nuclear imaging is performed owing to its better resolution and selectivity than non-nuclear imaging such as MRI and ultrasound.
The mobile gamma camera types include single, dual and…
Holographic Imaging Market Latest Technological Innovations on Holoxica, Zebra I …
Market Study Report Adds Global Holographic Imaging Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Emergence of 3D holographic imaging has revolutionized the medical imaging and surgery. The technology converts the given two dimensional MRI and CT scan imaging data into interactive virtual reality images. Using these images doctors…
Holographic Imaging Market : Eminent Players – EON Reality, Holoxica, Zebra Im …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc.
Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient…
Holographic Imaging Market Eminent Players – EON Reality, Holoxica, Zebra Imag …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc.
Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient anatomy…
Holographic Imaging Market Projections Reviewed On Holoxica, Zebra Imaging, Oviz …
The newly released research at Market Study Report titled “2017-2024 Global Holographic Imaging Consumption Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years.
Holographic Imaging Market size is set to exceed USD 3 billion by 2024. U.S. holographic imaging market accounted for significant industry share with expectations to witness healthy growth over coming years. Increasing biomedical research initiatives in holographic image…
Digital Imaging Market,Digital Imaging Industry, Global Digital Imaging Market,D …
Latest industry research report on: Global Digital Imaging Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report presents the worldwide Digital Imaging market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.
This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry…